Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

Clinical trial NCT04973293 · RECRUITING

Trial details

NCT number: NCT04973293
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Neoplasm Malignant

Start date: 2022-10-01
Primary completion: 2025-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.